Board/Management Information • Jul 25, 2024
Board/Management Information
Open in ViewerOpens in native device viewer


Verdellino (Bergamo, Italia), 25 July 2024 - The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. under the chairmanship of Marco Francesco Eigenmann has appointed, effective as of 2 August 2024, Mr. Marco Francesco Eigenmann as General Manager of the Company, who has been vested with powers relating to the ordinary management in its various forms. Pietro Oriani is a manager with over 30 years of career who has held roles of increasing joined the Group Intercos as Group Administration, Controlling and Reporting Director,
responsibility and leadership in Finance and in different sectors of Siemens Group, in 2011 he becoming the Group CFO in 2018.
The appointment of Pietro Oriani will contribute to the further success of Fine Foods & Pharmaceuticals N.T.M. S.p.A., thanks to his long managerial experience gained in leading international entities commented Marco Francesco Eigenmann, Chairman of the Company. Our goal is to continue to establish Fine Foods & Pharmaceuticals N.T.M.S.p.A. as a key player in the market of not only the pharmaceutical and nutraceutical as well as the cosmetics industry .
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia I am honoured and delighted by this new challenge, which I accept with enthusiasm and the determination to do my best. In my career I have always tried to be a team player; it is important and constructive to work in synergy, with shared goals. Full cooperation with the Chairman and the Board, keeping in mind the priorities and the interest of the Group and the stakeholders , said Pietro Oriani. To Giorgio Ferraris, who has been working at Fine Foods & Pharmaceuticals N.T.M. S.p.A. since
At today's Board meeting, Giorgio Ferraris announced his resignation as Director and CEO for personal reasons. The resignation will be effective as of the date of the Board's approval of the Half-Yearly Financial Report of the Fine Foods Group as of 30 June 2024 which is scheduled for 13 September 2024.
The Board, considering the skills and professionalism of Mr Oriani, has expressed a preliminary intention to coopt him as a Director and appointed him as Chief Executive Officer of the Company at the next Board meeting scheduled for 13 September 2024.
T. +39 035 4821382 [email protected] September 2013, the Board of Directors expressed its heartfelt thanks for the important work he has carried out over the years, in harmony with the company leadership and all of the management.


The unwavering commitment made by Giorgio Ferraris over the years has been an essential contribution to the growth and development of Fine Foods, my thanks go to the manager and the person with whom I have shared eleven years at Fine Foods and I also thank him for his availability to remain close to the Company as a strategic advisor , commented Marco Francesco Eigenmann, Chairman of the Company. Giorgio Ferraris qualifies as a non-independent executive director and based on the
information made available to the Company, as of today's date he holds No. 120,000 ordinary shares of the Company.
Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia T. +39 035 4821382 [email protected] independent CDMO (Contract Development and Manufacturing Organisation) It develops and manufactures contract products for the pharmaceutical, nutraceutical and cosmetics industries. Founded in 1984, Fine Foods organisation can provide successful design process and solid, long-term partnerships. The continuous search for reliability, product quality, ESG, and sustainable management of the Group's supply chain. Fine Foods is a benefit corporation which relies on certifications and ratings under international standards. These guarantee its future-oriented company.
For further information: Fine Foods & Pharmaceuticals N.T.M. S.p.A. Tel +39 035 4821382 Investor Relations: [email protected] Media Relations: [email protected]
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
CF / P.IVA IT 09320600969
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.